![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 21, 2015 10:09:49 AM
There are so many catalyst. Some we know, and others we do not. :)
I trust they know what they're doing and I'm going to be the patient shareholder that I've always been and give them room to do it. I can't help but debate the negative timeline points, as results can't be rushed. This is a biotech stock, so times of lull are shorted. Imagine it was determined months ago they weren't going to be presenting at ASCO. Shorts would have swarmed. In my mind, the company could have easily, and I mean easily, just bought booth space to ensure our share price was not manipulated over it. We only found out yesterday they wouldn't be presenting. To me that is very effective managment strategy, keep the world thinking they could reveal something any day, week or month. The more I see of this, the more I like. They potentially saved my share price from falling down by not revealing that card that the data wouldn't be there. But, did ASCO ever make sense? In my mind, not completely. I keep going back to that vaccine schedule, and this being immunotherapy, which needs even that last vaccine data to age (it's not like they can inject in May and Ph I ends that date (it needs months). The DATA not being ready, IS NOT the same thing as the data didn't get accepted. Only now, we're near the end of April, and so much closer to the next catalyst. I haven't even looked at the ticker, as it just doesn't matter, as we are always getting close to the next thing, and in the interim, the data is aging. Long hold shareholder think that way.
BUT, will I be here to debate, until I'm exhausted sometimes, all the negative points? Absolutely. I won't get angry doing it, as to me, it's not personal. I just don't read into it. Period.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM